Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00016835 · ClinicalTrials.gov registry record · Phase 2
Treating Periodontal Infection: Effects on Glycemic
A Phase 2 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 2
- Development phase
- 46
- Enrollment target
NCT00016835: Completed Phase 2 study, sponsored by University of Michigan.
NCT00016835 is a Phase 2 study that has completed, run by University of Michigan. The registered enrollment target is 46 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00016835, a Phase 2 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this project is to obtain important preliminary data necessary to support design of a full scale, multicenter randomized clinical trial (RCT) to evaluate the effect of treating periodontal infection on glycemic control in type 2 diabetes mellitus.
Interventions
- PROCEDURE Supra-gingival scaling and placebo
- PROCEDURE Subgingival scaling and metronidazole
- PROCEDURE Subgingival scaling and doxycycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2001-10-17 |
| Est. Completion | 2004-09-03 |
| Phase | Phase 2 |
What the finished NCT00016835 record still lists
NCT00016835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 3 interventions - of which Supra-gingival scaling and placebo is the first listed.
NCT00016835 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00016835 about?
NCT00016835 is a clinical study titled "Treating Periodontal Infection: Effects on Glycemic". The purpose of this project is to obtain important preliminary data necessary to support design of a full scale, multicenter randomized clinical trial (RCT) to evaluate the effect of treating periodontal infection on glycemic control in type 2 diabetes mellitus.
What is the current status of trial NCT00016835?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 2001-10-17. Estimated completion is 2004-09-03.
What interventions are being tested in trial NCT00016835?
The interventions under investigation include: Supra-gingival scaling and placebo (PROCEDURE), Subgingival scaling and metronidazole (PROCEDURE), Subgingival scaling and doxycycline (PROCEDURE).
Who is sponsoring clinical trial NCT00016835?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00016835's enrollment target sits among peer trials
46 1286th of 2000 higher than 705 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI